Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7093

1.

The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity.

Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehéricy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M; EADC -European Alzheimer's Disease Consortium and the ADNI - Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Sep 27. pii: S1552-5260(14)02468-6. doi: 10.1016/j.jalz.2014.05.1756. [Epub ahead of print]

PMID:
25267715
[PubMed - as supplied by publisher]
2.

DNA and neutral lipid contents of peripheral cells as predictive biomarkers of mild cognitive impairment and Alzheimer's disease: Highlights on the interest of a cytomic approach for the characterization of dementia.

Zarrouk A, Lizard G.

Cytometry A. 2014 Sep 26. doi: 10.1002/cyto.a.22572. [Epub ahead of print] No abstract available.

PMID:
25263350
[PubMed - as supplied by publisher]
3.

Biomarkers in dementia: clinical utility and new directions.

Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O'Brien JT, Fox NC, Halliday GM, Schott JM.

J Neurol Neurosurg Psychiatry. 2014 Sep 26. pii: jnnp-2014-307662. doi: 10.1136/jnnp-2014-307662. [Epub ahead of print]

PMID:
25261571
[PubMed - as supplied by publisher]
4.

Proteopathic tau seeding predicts tauopathy in vivo.

Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC, Belaygorod L, Cairns NJ, Holtzman DM, Diamond MI.

Proc Natl Acad Sci U S A. 2014 Sep 26. pii: 201411649. [Epub ahead of print]

PMID:
25261551
[PubMed - as supplied by publisher]
5.

Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging.

Brier MR, Thomas JB, Snyder AZ, Wang L, Fagan AM, Benzinger T, Morris JC, Ances BM.

Neurology. 2014 Sep 26. pii: 10.1212/WNL.0000000000000939. [Epub ahead of print]

PMID:
25261500
[PubMed - as supplied by publisher]
6.

White Matter Hyperintensities as Early and Independent Predictors of Alzheimer's Disease Risk.

Mortamais M, Sylvaine A, Ritchie K.

J Alzheimers Dis. 2014 Sep 26. [Epub ahead of print]

PMID:
25261452
[PubMed - as supplied by publisher]
7.

Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.

Eskildsen SF, Coupé P, Fonov VS, Pruessner JC, Collins DL; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2014 Aug 28. pii: S0197-4580(14)00548-X. doi: 10.1016/j.neurobiolaging.2014.04.034. [Epub ahead of print]

PMID:
25260851
[PubMed - as supplied by publisher]
8.

Empowering imaging biomarkers of Alzheimer's disease.

Gutman BA, Wang Y, Yanovsky I, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; for the Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2014 Aug 27. pii: S0197-4580(14)00544-2. doi: 10.1016/j.neurobiolaging.2014.05.038. [Epub ahead of print]

PMID:
25260848
[PubMed - as supplied by publisher]
9.

Is there an MCI reversion to cognitively normal? Analysis of Alzheimer's disease biomarkers profiles.

Park MH, Han C.

Int Psychogeriatr. 2014 Sep 26:1-9. [Epub ahead of print]

PMID:
25255915
[PubMed - as supplied by publisher]
10.

Enhancement of Neurogenesis and Memory by a Neurotrophic Peptide in Mild to Moderate Traumatic Brain Injury.

Chohan MO, Bragina O, Kazim SF, Statom G, Baazaoui N, Bragin D, Iqbal K, Nemoto E, Yonas H.

Neurosurgery. 2014 Sep 24. [Epub ahead of print]

PMID:
25255260
[PubMed - as supplied by publisher]
11.

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease.

Rosén C, Andersson CH, Andreasson U, Molinuevo JL, Bjerke M, Rami L, Lladó A, Blennow K, Zetterberg H.

Dement Geriatr Cogn Dis Extra. 2014 Jul 31;4(2):297-304. doi: 10.1159/000362164. eCollection 2014 May.

PMID:
25254036
[PubMed]
Free PMC Article
12.

P300 Amplitude in Alzheimer's Disease: A Meta-Analysis and Meta-Regression.

Hedges D, Janis R, Mickelson S, Keith C, Bennett D, Brown BL.

Clin EEG Neurosci. 2014 Sep 23. pii: 1550059414550567. [Epub ahead of print]

PMID:
25253434
[PubMed - as supplied by publisher]
13.

APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.

Dixon RA, DeCarlo CA, MacDonald SW, Vergote D, Jhamandas J, Westaway D.

Front Aging Neurosci. 2014 Sep 5;6:236. doi: 10.3389/fnagi.2014.00236. eCollection 2014.

PMID:
25249975
[PubMed]
Free PMC Article
14.

A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype.

Veitinger M, Oehler R, Umlauf E, Baumgartner R, Schmidt G, Gerner C, Babeluk R, Attems J, Mitulovic G, Rappold E, Lamont J, Zellner M.

Acta Neuropathol. 2014 Sep 24. [Epub ahead of print]

PMID:
25248508
[PubMed - as supplied by publisher]
15.

Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers.

Kabiraj P, Marin JE, Varela-Ramirez A, Zubia ES, Narayan M.

ACS Chem Neurosci. 2014 Sep 23. [Epub ahead of print]

PMID:
25247703
[PubMed - as supplied by publisher]
16.

A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis.

Rakesh KS, Jagadish S, Vinayaka AC, Hemshekhar M, Paul M, Thushara RM, Sundaram MS, Swaroop TR, Mohan CD, Basappa, Sadashiva MP, Kemparaju K, Girish KS, Rangappa KS.

PLoS One. 2014 Sep 19;9(9):e107182. doi: 10.1371/journal.pone.0107182. eCollection 2014.

PMID:
25238069
[PubMed - in process]
Free PMC Article
17.

[Prediction of Alzheimer's dementia.]

Jessen F, Dodel R.

Nervenarzt. 2014 Sep 19. [Epub ahead of print] German.

PMID:
25231823
[PubMed - as supplied by publisher]
18.

Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.

González-Domínguez R, García-Barrera T, Gómez-Ariza JL.

Anal Bioanal Chem. 2014 Sep 18. [Epub ahead of print]

PMID:
25230597
[PubMed - as supplied by publisher]
19.

Spreading of Amyloid, Tau, and Microvascular Pathology in Alzheimer's Disease: Findings from Neuropathological and Neuroimaging Studies.

Thal DR, Attems J, Ewers M.

J Alzheimers Dis. 2014 Sep 16. [Epub ahead of print]

PMID:
25227313
[PubMed - as supplied by publisher]
20.

Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis.

Proitsi P, Lupton MK, Velayudhan L, Newhouse S, Fogh I, Tsolaki M, Daniilidou M, Pritchard M, Kloszewska I, Soininen H, Mecocci P, Vellas B; Alzheimer's Disease Neuroimaging Initiative, Williams J; GERAD1 Consortium, Stewart R, Sham P, Lovestone S, Powell JF.

PLoS Med. 2014 Sep 16;11(9):e1001713. doi: 10.1371/journal.pmed.1001713. eCollection 2014 Sep.

PMID:
25226301
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk